Investigating how testosterone affects tau protein in women with Alzheimer's disease
Role of Testosterone in Modulating Tau Pathogenesis in Females
This study is looking at how testosterone levels might affect the buildup of tau protein in women, especially related to Alzheimer's disease, to see if boosting testosterone could help women who are at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11088855 on NIH RePORTER |
What this research studies
This research explores the relationship between testosterone levels and tau protein aggregation in women, particularly in the context of Alzheimer's disease. It aims to understand why women tend to exhibit more tau pathology than men and how low testosterone may contribute to this difference. By examining the molecular mechanisms involved, the study seeks to establish a causal link between testosterone and tau, and to evaluate the potential benefits of testosterone therapy for women at risk of Alzheimer's disease. The research utilizes clinical data and aims to inform future therapeutic strategies tailored to female patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk for Alzheimer's disease, particularly those with low testosterone levels or genetic predispositions such as ApoE4 carriers.
Not a fit: Patients who are male or those who do not have any risk factors for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that utilize testosterone to mitigate tau pathology and improve cognitive function in women at risk for Alzheimer's disease.
How similar studies have performed: Previous studies have indicated a correlation between testosterone levels and cognitive function in women, suggesting that this research could build on established findings, although the specific causal relationship is still being explored.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Chen, Xu — University of California, San Diego
- Study coordinator: Chen, Xu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.